Aldava, Churchi, JR. A.

HRN: 19-64-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/27/2023
09/03/2023
IVTT
72mg
Q6hrs
Foreign Body Ingestion
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: